SKSabrina Khan

Sabrina Khan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sabrina Khan has a total of 53 co-authors. Here are the top co-authors by number of shared publications:

  • Angela Gomez-Simmonds

    Department of Medicine, Division of Infectious Diseases, Columbia University Irving Medical Center, 630W 168th Street, New York, NY, 10032, USA

    3 shared publications
  • Anne-Catrin Uhlemann

    Columbia University

    3 shared publications
  • Medini K. Annavajhala

    Division of Infectious Diseases, Columbia University Irving Medical Center, New York, New York, USA

    3 shared publications
  • Nenad Macesic

    Department of Medicine, Division of Infectious Diseases, Columbia University Irving Medical Center, 630W 168th Street, New York, NY, 10032, USA

    3 shared publications
  • Anne-Catrin Uhlemann

    Microbiome and Pathogen Genomics Core, Department of Medicine, Columbia University Medical Center, New York, USA

    2 shared publications
  • Elizabeth C. Verna

    Division of Digestive and Liver Diseases, Center for Liver Disease and Transplantation, Columbia University Irving Medical Center, NY Presbyterian Hospital, New York, NY, USA

    2 shared publications

Latest Publications

  • Open Access

    Colonizing multidrug-resistant bacteria and the longitudinal evolution of the intestinal microbiome after liver transplantation

    by Medini K. Annavajhala, Angela Gomez-Simmonds, Nenad Macesic, Sean B. Sullivan, Anna Kress, Sabrina D. Khan, Marla J. Giddins, Stephania Stump, Grace I. Kim, Ryan Narain, et al.

    Infections by multidrug-resistant bacteria (MDRB) remain a leading cause of morbidity and mortality after liver transplantation (LT). Gut dysbiosis characteristic of end-stage liver disease may predispose patients to intestinal MDRB colonization and infection, in turn exacerbating dysbiosis. However, relationships between MDRB colonization and dysbiosis after LT remain unclear. We prospectively recruited 177 adult patients undergoing LT at a single tertiary care center. 16 S V3-V4 rRNA sequencing was performed on 723 fecal samples collected pre-LT and periodically until one-year post-LT to test whether MDRB colonization was associated with decreased microbiome diversity. In multivariate linear mixed-effect models, MDRB colonization predicts reduced Shannon α-diversity, after controlling for underlying liver disease, antibiotic exposures, and clinical complications. Importantly, pre-LT microbial markers predict subsequent colonization by MDRB. Our results suggest MDRB colonization as a major, previously unrecognized, marker of persistent dysbiosis. Therapeutic approaches accounting for microbial and clinical factors are needed to address post-transplant microbiome health.


  • Escherichia coli Harboring mcr-1 in a Cluster of Liver Transplant Recipients: Detection through Active Surveillance and Whole-Genome Sequencing

    by Nenad Macesic, Sabrina Khan, Marla J. Giddins, Daniel E. Freedberg, Susan Whittier, Daniel A. Green, E. Yoko Furuya, Elizabeth C. Verna, Medini K. Annavajhala, Angela Gomez-Simmonds, et al.

    mcr-1 , a plasmid-associated gene for colistin resistance, was first described in China in 2015, but its spread in the United States is unknown. We report detection of mcr-1 -carrying Escherichia coli ST117 in a cluster of three liver transplant recipients.


  • Pathogen colonization of the gastrointestinal microbiome at intensive care unit admission and risk for subsequent death or infection

    by Daniel E. Freedberg, Margaret J. Zhou, Margot E. Cohen, Medini K. Annavajhala, Sabrina Khan, Dagmara I. Moscoso, Christian Brooks, Susan Whittier, David H. Chong, Anne-Catrin Uhlemann, et al.

    Loss of colonization resistance within the gastrointestinal microbiome facilitates the expansion of pathogens and has been associated with death and infection in select populations. We tested whether gut microbiome features at the time of intensive care unit (ICU) admission predict death or infection.


  • Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in bla KPC-2 -Harboring Klebsiella pneumoniae Sequence Type 307 Isolates

    by Marla J. Giddins, Nenad Macesic, Medini K. Annavajhala, Stephania Stump, Sabrina Khan, Thomas H. McConville, Monica Mehta, Angela Gomez-Simmonds, Anne-Catrin Uhlemann

    Ceftazidime-avibactam (CAZ-AVI) is a promising novel treatment for infections caused by carbapenem-resistant Enterobacteriaceae (CRE). Despite improved treatment outcomes compared to those achieved with aminoglycoside- and colistin-based regimens, the rapid evolution of CAZ-AVI resistance during treatment has previously been reported in Klebsiella pneumoniae sequence type 258 (ST258) bla KPC-3 -harboring isolates. Here, we report the stepwise evolution and isolation of two phenotypically distinct CAZ-AVI-resistant Klebsiella pneumoniae isolates from a patient with pancreatitis. All susceptible ( n = 3) and resistant ( n = 5) isolates were of the ST307 clonal background, a rapidly emerging clone. Taking advantage of short-read Illumina and long-read Oxford Nanopore sequencing and full-length assembly of the core chromosome and plasmids, we demonstrate that CAZ-AVI resistance first occurred through a 532G → T bla KPC-2 point mutation in bla KPC-2 (D179Y protein substitution) following only 12 days of CAZ-AVI exposure. While subsequent isolates exhibited substantially decreased meropenem (MEM) MICs (≤2 μg/ml), later cultures demonstrated a second CAZ-AVI resistance phenotype with a lower CAZ-AVI MIC (12 μg/ml) but also MEM resistance (MIC > 128 μg/ml). These CAZ-AVI- and MEM-resistant isolates showed evidence of multiple genomic adaptations, mainly through insertions and deletions. This included amplification and transposition of wild-type bla KPC-2 into a novel plasmid, an IS 1 insertion upstream of ompK36 , and disruption of the rfb gene locus in these isolates. Our findings illustrate the potential of CAZ-AVI resistance to emerge in non- K. pneumoniae ST258 clonal backgrounds and alternative bla KPC variants. These results raise concerns about the strong selective pressures incurred by novel carbapenemase inhibitors, such as avibactam, on isolates previously considered invulnerable to CAZ-AVI resistance. There is an urgent need to further characterize non-KPC-mediated modes of carbapenem resistance and the intrinsic bacterial factors that facilitate the rapid emergence of resistance during treatment.


  • Topical vancomycin to reduce surgical-site infections in neurosurgery: Study protocol for a multi-center, randomized controlled trial

    by Alexander J. Jonokuchi, Jared Knopman, Ryan E. Radwanski, Moises A. Martinez, Blake Eaton Samuel Taylor, Michael Rothbaum, Sean Sullivan, Trae R. Robison, Eric Lo, Brandon R. Christophe, et al.


  • Open Access

    The Surface Protein SdrF Mediates Staphylococcus epidermidis Adherence to Keratin

    by Sheetal Trivedi, Anne-Catrin Uhlemann, Philippe Herman-Bausier, Sean B Sullivan, Madeleine G Sowash, Elizabeth Y Flores, Sabrina D Khan, Yves F Dufrêne, Franklin D Lowy

    Staphylococcus epidermidis, a major component of skin flora, is an opportunist, often causing prosthetic device infections. A family of structurally related proteins mediates staphylococcal attachment to host tissues, contributing to the success of S. epidermidis as a pathogen. We examined the ability of the surface protein SdrF to adhere to keratin, a major molecule expressed on the skin surface. A heterologous Lactococcus lactis expression system was used to express SdrF and its ligand-binding domains. Adherence to keratin types 1 and 10, human foreskin keratinocytes, and nasal epithelial cells was examined. SdrF bound human keratins 1 and 10 and adhered to keratinocytes and epithelial cells. Binding involved both the A and B domains. Anti-SdrF antibodies reduced adherence of S. epidermidis to keratin and keratinocytes. RNA interference reduced keratin synthesis in keratinocytes and, as a result, SdrF adherence. Direct force measurements using atomic force microscopy showed that SdrF mediates bacterial adhesion to keratin 10 through strong and weak bonds involving the A and B regions; strong adhesion was primarily mediated by the A region. These studies demonstrate that SdrF mediates adherence to human keratin and suggest that SdrF may facilitate S. epidermidis colonization of the skin.